There have been 50 recent insider transactions recorded for Leap Therapeutics, Inc. (LPTX), including 33 buys and 17 sells. Total insider buying was valued at $4.88M and total insider selling at $18.67K.
Notable insiders with recent activity include Mirabelli Christopher, Lawlor Augustine, Onsi Douglas E. Insider transactions can provide insights into how company leadership views the stock's valuation and future prospects.
Insider Transactions — LPTX
| Date |
Name |
Role |
Transaction |
Shares |
Avg. Price |
Value |
Shares Owned |
| 2025-03-28 |
Mirabelli Christopher |
Chairman of the Board |
Option Exercise (Sell) |
22,500 |
- |
- |
- |
| 2025-03-28 |
Lawlor Augustine |
Chief Operating Officer |
Option Exercise (Sell) |
22,500 |
- |
- |
- |
| 2025-03-28 |
Onsi Douglas E |
CEO,cfo,pres.,gc,treas.&sec. |
Option Exercise (Sell) |
32,500 |
- |
- |
- |
| 2025-03-28 |
Sirard Cynthia |
Chief Medical Officer |
Option Exercise (Sell) |
22,500 |
- |
- |
- |
| 2025-03-28 |
O'mahony John Mark |
Chief Manufacturing Officer |
Option Exercise (Sell) |
22,500 |
- |
- |
- |
| 2025-03-28 |
Granfield Christine |
VP, Head of Reg Affairs/qual |
Option Exercise (Sell) |
22,500 |
- |
- |
- |
| 2025-03-28 |
Baum Jason |
Chief Scientific Officer |
Option Exercise (Sell) |
22,500 |
- |
- |
- |
| 2024-11-13 |
Cavanaugh James H |
Director |
Option Exercise (ITM) |
213 |
$2.82 |
$600.66 |
- |
| 2024-11-13 |
Mirabelli Christopher |
Chairman of the Board |
Option Exercise (ITM) |
2,136 |
$2.82 |
$6.02K |
- |
| 2024-11-13 |
Lawlor Augustine |
Chief Operating Officer |
Option Exercise (ITM) |
2,136 |
$2.82 |
$6.02K |
- |
| 2024-11-13 |
Onsi Douglas E |
CEO,cfo,pres.,gc,treas.&sec. |
Option Exercise (ITM) |
2,136 |
$2.82 |
$6.02K |
- |
| 2024-10-02 |
Cavanaugh James H |
Director |
RSU Award |
25,000 |
$2.45 |
$61.25K |
25,000 |
| 2024-10-02 |
Mirabelli Christopher |
Director |
RSU Award |
85,000 |
$2.45 |
$208.25K |
85,000 |
| 2024-10-02 |
Lawlor Augustine |
Chief Operating Officer |
RSU Award |
85,000 |
$2.45 |
$208.25K |
85,000 |
| 2024-10-02 |
Onsi Douglas E |
CEO,cfo,pres.,gc,treas.,&sec. |
RSU Award |
170,000 |
$2.45 |
$416.5K |
170,000 |
| 2024-10-02 |
Li William |
Director |
RSU Award |
25,000 |
$2.45 |
$61.25K |
25,000 |
| 2024-10-02 |
Loscalzo Joseph |
Director |
RSU Award |
25,000 |
$2.45 |
$61.25K |
25,000 |
| 2024-10-02 |
Mashiach Nissim |
Director |
RSU Award |
25,000 |
$2.45 |
$61.25K |
25,000 |
| 2024-10-02 |
Dietz Thomas John |
Director |
RSU Award |
30,000 |
$2.45 |
$73.5K |
30,000 |
| 2024-10-02 |
Richard Christian M |
Director |
RSU Award |
25,000 |
$2.45 |
$61.25K |
25,000 |
| 2024-10-02 |
Sirard Cynthia |
Chief Medical Officer |
RSU Award |
85,000 |
$2.45 |
$208.25K |
85,000 |
| 2024-10-02 |
O'mahony John Mark |
Chief Manufacturing Officer |
RSU Award |
85,000 |
$2.45 |
$208.25K |
85,000 |
| 2024-10-02 |
Granfield Christine |
VP, Head of Reg Affairs/qual |
RSU Award |
85,000 |
$2.45 |
$208.25K |
85,000 |
| 2024-10-02 |
Martin Patricia A. |
Director |
RSU Award |
25,000 |
$2.45 |
$61.25K |
25,000 |
| 2024-10-02 |
Schilsky Richard |
Director |
RSU Award |
25,000 |
$2.45 |
$61.25K |
25,000 |
| 2024-10-02 |
Baum Jason |
Chief Scientific Officer |
RSU Award |
85,000 |
$2.45 |
$208.25K |
85,000 |
| 2024-04-10 |
Gilead Sciences, Inc. |
10 Percent Owner |
Disposition |
- |
- |
- |
5,319,148 |
| 2024-01-29 |
Cavanaugh James H |
Director |
RSU Award |
25,000 |
$2.68 |
$67K |
25,000 |
| 2024-01-29 |
Mirabelli Christopher |
Chairman of the Board |
RSU Award |
85,000 |
$2.68 |
$227.8K |
85,000 |
| 2024-01-29 |
Lawlor Augustine |
Chief Operating Officer |
RSU Award |
85,000 |
$2.68 |
$227.8K |
85,000 |
| 2024-01-29 |
Onsi Douglas E |
CEO,cfo,pres.,gc,treas.,&sec. |
RSU Award |
170,000 |
$2.68 |
$455.6K |
170,000 |
| 2024-01-29 |
Li William |
Director |
RSU Award |
25,000 |
$2.68 |
$67K |
25,000 |
| 2024-01-29 |
Loscalzo Joseph |
Director |
RSU Award |
25,000 |
$2.68 |
$67K |
25,000 |
| 2024-01-29 |
Mashiach Nissim |
Director |
RSU Award |
25,000 |
$2.68 |
$67K |
25,000 |
| 2024-01-29 |
Dietz Thomas John |
Director |
RSU Award |
30,000 |
$2.68 |
$80.4K |
30,000 |
| 2024-01-29 |
Richard Christian M |
Director |
RSU Award |
25,000 |
$2.68 |
$67K |
25,000 |
| 2024-01-29 |
Sirard Cynthia |
Chief Medical Officer |
RSU Award |
85,000 |
$2.68 |
$227.8K |
85,000 |
| 2024-01-29 |
O'mahony John Mark |
Chief Manufacturing Officer |
RSU Award |
85,000 |
$2.68 |
$227.8K |
85,000 |
| 2024-01-29 |
Granfield Christine |
VP, Head of Reg Affairs/qual |
RSU Award |
85,000 |
$2.68 |
$227.8K |
85,000 |
| 2024-01-29 |
Martin Patricia A. |
Director |
RSU Award |
25,000 |
$2.68 |
$67K |
25,000 |
| 2024-01-29 |
Schilsky Richard |
Director |
RSU Award |
25,000 |
$2.68 |
$67K |
25,000 |
| 2024-01-29 |
Baum Jason |
Chief Scientific Officer |
RSU Award |
85,000 |
$2.68 |
$227.8K |
85,000 |
| 2024-01-26 |
Mirabelli Christopher |
Chairman of the Board |
Option Exercise (Sell) |
5,000 |
- |
- |
- |
| 2024-01-26 |
Lawlor Augustine |
Chief Operating Officer |
Option Exercise (Sell) |
5,000 |
- |
- |
- |
| 2024-01-26 |
Onsi Douglas E |
CEO,cfo,pres.,gc,treas.,&sec. |
Option Exercise (Sell) |
7,500 |
- |
- |
- |
| 2024-01-26 |
Sirard Cynthia |
Chief Medical Officer |
Option Exercise (Sell) |
5,000 |
- |
- |
- |
| 2024-01-26 |
O'mahony John Mark |
Chief Manufacturing Officer |
Option Exercise (Sell) |
5,000 |
- |
- |
- |
| 2023-08-23 |
Cavanaugh James H |
Director |
RSU Award |
15,000 |
$2.21 |
$33.15K |
15,000 |
| 2023-08-23 |
Mirabelli Christopher |
Chairman of the Board |
RSU Award |
70,000 |
$2.21 |
$154.7K |
70,000 |
| 2023-08-23 |
Lawlor Augustine |
Chief Operating Officer |
RSU Award |
70,000 |
$2.21 |
$154.7K |
70,000 |
■ Informative Buy/Sell — open market transaction (most significant)
■ Uninformative Buy — award, option exercise, conversion
■ Uninformative Sell — tax withholding, award vest sale
■ Neutral — gift, trust, expiry
